Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M Mañosa Ciria"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C J Suarez Ferrer, F Mesonero, B Caballol, M P Ballester, I Baston Rey, A Castaño Garcia, J Miranda Bautista, R Saiz Chumillas, J M Benitez, L Sanchez Delgado, A Lopez-Garcia, C Rubin de Celio, I Alonso Abreu, L Melcarne, R Plaza Santos, M Marques Cami, A Caballero Mateos, C Gomez Diez, M Calafat, H Alonso Galan, P Vega Vilaamil, B Castro Sensosian, A Guerro Moya, C Y Rodriguez Diaz, K Spicakova, N Manceñido Marcos, G Molina, L De Castro, A Rodriguez Angulo, L Cuevas del Campo, M C Rodriguez Grau, F Ramirez, B Gomez Pastrana, I Gonzalez Partida, B Botella Mateu, E Peña Gonzalez, E Iyo, A Elosua Gonzalez, M Mañosa Ciria, M Barreiro-De Acosta
Publikováno v:
Journal of Crohn's and Colitis. 16:i449-i450
Background The use of biological drugs for the treatment of IBD in elderly patients is becoming more frequent in our environment. However, given the greater risk of these patients to develop related adverse effects, the profile of the patients in who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2c8d1dc68c1aacac7020e1b8842113f
https://doi.org/10.1093/ecco-jcc/jjab232.608
https://doi.org/10.1093/ecco-jcc/jjab232.608
Autor:
C J Suarez Ferrer, F Mesonero, B Caballol, M P Ballester, I Baston Rey, A Castaño Garcia, J Miranda Bautista, R Saiz Chumillas, J M Benitez, L Sanchez Delgado, A Lopez-Garcia, C Rubin de Celix, A Lopez Sanroma, M D Martin-Arranz, A Fernández-Clotet, V Merino Murgui, C Calviño Suárez, P Florez, M E Lobato matilla, B Sicilia, P Soto Escribano, C Maroto Martin, I Alonso Abreu, L Melcarne, R Plaza Santos, M Marques Cami, A Caballero Mateos, C Gómez Díez, M Calafat, H Alonso Galan, P Vega Villaamil, B Castro Senosiain, A Guerro Moya, C Y Rodriguez Diaz, K Spicakova, N Manceñido Marcos, G Molina, L De Castro, M Mañosa Ciria, M Barreiro-De Acosta
Publikováno v:
Journal of Crohn's and Colitis. 16:i400-i401
Background The most feared adverse events related to biological treatment in patients with inflammatory bowel disease (IBD) are the development of tumors and / or serious infections. These events are generally more frequent in elderly patients, so th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e55f479ae9ddc2a404bc8ee126606cb
https://doi.org/10.1093/ecco-jcc/jjab232.537
https://doi.org/10.1093/ecco-jcc/jjab232.537
Autor:
Beatriz Sicilia, O. García‐Bosch, Rufo Lorente, E. Iglesias, Javier P. Gisbert, Fernando Gomollón, L Ramos, Eneida, Eduardo Doménech, C González-Muñoza, M.I. Vera, A. Rodriguez, Fiorella Cañete, Miguel Minguez, Antonio López-Sanromán, M. Barreiro-de Acosta, Paola Varela, M Esteve, Daniel Carpio, Miguel Rivero, Fernando Bermejo, Hernández, Emigdio Rodríguez, Luis Bujanda, Santiago García-López, M Sierra, A Gutiérrez Casbas, X. Calvet, María Dolores Martín-Arranz, Olga Merino, Elena Ricart, Sabino Riestra, Jesus Barrio, Lucía Márquez, M Calafat, Pilar Nos, Cristina Alba, J.L. Pérez-Calle, José Luis Cabriada, Jordi Guardiola, M. Mañosa Ciria
Publikováno v:
Journal of Crohn's and Colitis. 15:S069-S070
Background A less aggressive phenotype of Crohn’s disease (CD) has been reported in patients with elderly onset CD. Despite this, similar surgical rates among younger and older CD patients have been reported. However, scarce data are available abou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4e2005eb58eed87cb21d40eb1163cf2
https://doi.org/10.1093/ecco-jcc/jjab073.070
https://doi.org/10.1093/ecco-jcc/jjab073.070
Autor:
E Sainz, M Calafat, B Botella Mateu, P Vega Villaamil, E Iyo, I Gonzalez Partida, A Caballero Mateos, Liczandro Hernandez, L Melcarne, C Calviño Suárez, Agnès Fernández-Clotet, H Alonso Galan, L Cuevas del Campo, P Perez Galindo, A López Sanromán, M Marques Cami, A López-García, M D Martin-Arranz, C Rubín de Célix, E Gonzalez Peña, Beatriz Sicilia, M C Rodriguez Grau, B Castro Senosiain, Francisco Mesonero, C Suarez Ferrer, Iria Bastón-Rey, J L Rueda García, M. Barreiro-de Acosta, Florina Ramírez, A Elosua Gonzalez, B Gomez Pastrana, R M Saiz Chumillas, C.Y. Rodríguez Díaz, R Plaza Santos, B Caballol, M. Mañosa Ciria
Publikováno v:
Journal of Crohn's and Colitis. 15:S363-S364
Background Biological drugs are being increasingly used for the treatment of inflammatory bowel diseases (IBD) in elderly patients. Despite the particular characteristics of this population subgroup, the efficacy and safety of these treatments in rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dda8646bbe4a08114cafa7d0c6b89c0e
https://doi.org/10.1093/ecco-jcc/jjab076.462
https://doi.org/10.1093/ecco-jcc/jjab076.462
Autor:
E Hinojosa, A Núñez Alonso, Noemí Manceñido, E Sainz, Jordi Guardiola, E. Domènech, Eneida Registry, Ana Yaiza Carbajo, Mario Calvo, Fiorella Cañete, M Calafat, Josiane Márcia de Castro, J.P. Gisbert, E Sánchez-Rodríguez, Pilar Nos, M. Mañosa Ciria
Publikováno v:
Journal of Crohn's and Colitis. 14:S554-S555
Background Anti-TNF and thiopurines are the only drugs that demonstrated efficacy in preventing postoperative recurrence (POR) in Crohn’s disease (CD). However, in some cases, these drugs are contraindicated or have previously failed. Vedolizumab w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1af2230bdaf70e878901a5141d6ca980
https://doi.org/10.1093/ecco-jcc/jjz203.809
https://doi.org/10.1093/ecco-jcc/jjz203.809
Autor:
M Mañosa Ciria, A Fernandez-Clotet, A Hernández-Camba, R Muñoz Pérez, M Iborra, M Sierra, L Márquez, P Delgado-Guillena, D Busquets, M Van Domselaar, E Girona, E Sánchez-Rodríguez, M D Martín-Arranz, R Lorente, D Casas-Deza, M Boscá, F Cañete, M Calafat, E Domènech
Publikováno v:
Journal of Crohn's and Colitis. 14:S410-S410
Background Anti-TNF and thiopurines are the only drugs that demonstrated efficacy in preventing postoperative recurrence (POR) in Crohn’s disease (CD). However, in some cases these drugs are contraindicated or have previously failed. Recently, uste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83aa831fccb9312f1bd2cae53d8b3f08
https://doi.org/10.1093/ecco-jcc/jjz203.591
https://doi.org/10.1093/ecco-jcc/jjz203.591
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.